Comprehensive Stock Comparison
Compare MicroAlgo Inc. (MLGO) vs Synopsys, Inc. (SNPS) Stock
Analyze side-by-side fundamentals, valuation, growth, and profitability to decide which stock is the better buy.
Selected Stocks
Add up to 10 tickers. Use presets or search to get started.
Quick Verdict
| Category | Winner | Why |
|---|---|---|
| Growth | SNPS | 15.1% revenue growth vs MLGO's -9.2% |
| Value | MLGO | Lower P/E (6.5x vs 28.7x) |
| Quality / Margins | SNPS | 13.8% net margin vs MLGO's 11.1% |
| Stability / Safety | MLGO | Beta 0.16 vs SNPS's 1.37, lower leverage |
| Dividends | Tie | Neither pays a meaningful dividend |
| Momentum (1Y) | SNPS | -9.5% vs MLGO's -97.1% |
| Efficiency (ROA) | SNPS | 2.3% ROA vs MLGO's 2.1%, ROIC 3.0% vs 14.1% |
Who Each Stock Is For
Income & stability
Growth exposure
Long-term compounding (10Y)
Sleep-well-at-night portfolio
Defensive / Recession hedge
Business Model
What each company does and how it makes money
MicroAlgo develops central processing algorithm solutions that optimize computing performance for clients in internet advertising, gaming, and intelligent chips. It generates revenue primarily through algorithm services — including optimization, data processing, and intelligence services — and secondarily through intelligent chip resale and software development. The company's competitive advantage lies in its proprietary algorithms that accelerate computing power without requiring hardware upgrades, offering cost-effective performance enhancements.
Synopsys is a leading provider of electronic design automation software and semiconductor intellectual property used to design and test integrated circuits. The company generates revenue primarily from software license sales (~60% of revenue) and maintenance/services (~40%), with its IP segment—which includes interface, analog, and security IP—growing rapidly. Its competitive moat stems from deep technical expertise, long-standing customer relationships in the complex semiconductor design ecosystem, and high switching costs for its mission-critical tools.
Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Financial Metrics Comparison
Side-by-side fundamentals across 2 stocks. BestLagging
Financial Scorecard
SNPS leads in 2 of 6 categories (Financial Metrics, Total Returns). MLGO leads in 2 (Valuation Metrics, Profitability & Efficiency). 1 tied.
Financial Metrics (TTM)
SNPS is the larger business by revenue, generating $8.0B annually — 130.9x MLGO's $61M. Profitability is closely matched — net margins range from 13.8% (SNPS) to 11.1% (MLGO). On growth, SNPS holds the edge at +65.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | MLGOMicroAlgo Inc. | SNPSSynopsys, Inc. |
|---|---|---|
| RevenueTrailing 12 months | $61M | $8.0B |
| EBITDAEarnings before interest/tax | $4M | $1.7B |
| Net IncomeAfter-tax profit | $7M | $1.1B |
| Free Cash FlowCash after capex | $9M | $2.3B |
| Gross MarginGross profit ÷ Revenue | +26.8% | +75.1% |
| Operating MarginEBIT ÷ Revenue | +5.8% | +10.8% |
| Net MarginNet income ÷ Revenue | +11.1% | +13.8% |
| FCF MarginFCF ÷ Revenue | +14.9% | +28.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | -34.3% | +65.5% |
| EPS Growth (YoY)Latest quarter vs prior year | -8.2% | -78.8% |
Valuation Metrics
At 6.5x trailing earnings, MLGO trades at a 87% valuation discount to SNPS's 51.5x P/E.
| Metric | MLGOMicroAlgo Inc. | SNPSSynopsys, Inc. |
|---|---|---|
| Market CapShares × price | $36M | $79.3B |
| Enterprise ValueMkt cap + debt − cash | -$85M | $90.7B |
| Trailing P/EPrice ÷ TTM EPS | 6.49x | 51.49x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 28.67x |
| PEG RatioP/E ÷ EPS growth rate | — | 3.82x |
| EV / EBITDAEnterprise value multiple | -30.45x | 57.55x |
| Price / SalesMarket cap ÷ Revenue | 0.48x | 11.24x |
| Price / BookPrice ÷ Book value/share | 0.23x | 2.36x |
| Price / FCFMarket cap ÷ FCF | 8.77x | 58.75x |
Profitability & Efficiency
SNPS delivers a 3.6% return on equity — every $100 of shareholder capital generates $4 in annual profit, vs $2 for MLGO. MLGO carries lower financial leverage with a 0.16x debt-to-equity ratio, signaling a more conservative balance sheet compared to SNPS's 0.50x. On the Piotroski fundamental quality scale (0–9), MLGO scores 4/9 vs SNPS's 3/9, reflecting mixed financial health.
| Metric | MLGOMicroAlgo Inc. | SNPSSynopsys, Inc. |
|---|---|---|
| ROE (TTM)Return on equity | +2.1% | +3.6% |
| ROA (TTM)Return on assets | +2.1% | +2.3% |
| ROICReturn on invested capital | +14.1% | +3.0% |
| ROCEReturn on capital employed | +2.9% | +3.3% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 3 |
| Debt / EquityFinancial leverage | 0.16x | 0.50x |
| Net DebtTotal debt minus cash | -$121M | $11.4B |
| Cash & Equiv.Liquid assets | $144M | $2.9B |
| Total DebtShort + long-term debt | $23M | $14.3B |
| Interest CoverageEBIT ÷ Interest expense | 25.26x | 6.38x |
Total Returns (with DRIP)
A $10,000 investment in SNPS five years ago would be worth $16,288 today (with dividends reinvested), compared to $1 for MLGO. Over the past 12 months, SNPS leads with a -9.5% total return vs MLGO's -97.1%. The 3-year compound annual growth rate (CAGR) favors SNPS at 4.4% vs MLGO's -93.3% — a key indicator of consistent wealth creation.
| Metric | MLGOMicroAlgo Inc. | SNPSSynopsys, Inc. |
|---|---|---|
| YTD ReturnYear-to-date | -30.3% | -13.8% |
| 1-Year ReturnPast 12 months | -97.1% | -9.5% |
| 3-Year ReturnCumulative with dividends | -100.0% | +13.8% |
| 5-Year ReturnCumulative with dividends | -100.0% | +62.9% |
| 10-Year ReturnCumulative with dividends | -100.0% | +825.1% |
| CAGR (3Y)Annualised 3-year return | -93.3% | +4.4% |
Risk & Volatility
MLGO is the less volatile stock with a 0.16 beta — it tends to amplify market swings less than SNPS's 1.37 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SNPS currently trades 63.5% from its 52-week high vs MLGO's 0.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | MLGOMicroAlgo Inc. | SNPSSynopsys, Inc. |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.16x | 1.37x |
| 52-Week HighHighest price in past year | $972.00 | $651.73 |
| 52-Week LowLowest price in past year | $3.35 | $365.74 |
| % of 52W HighCurrent price vs 52-week peak | +0.4% | +63.5% |
| RSI (14)Momentum oscillator 0–100 | 41.8 | 42.9 |
| Avg Volume (50D)Average daily shares traded | 149K | 1.7M |
Analyst Outlook
| Metric | MLGOMicroAlgo Inc. | SNPSSynopsys, Inc. |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy |
| Price TargetConsensus 12-month target | — | $529.44 |
| # AnalystsCovering analysts | — | 27 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | — |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
Historical Charts
Charts are rendered on first load. Hover for details.
Chart 1Total Return — 5 Years (Rebased to 100)
| Stock | Apr 21 | Feb 26 | Change |
|---|---|---|---|
| MicroAlgo Inc. (MLGO) | 100 | 0.01 | -100.0% |
| Synopsys, Inc. (SNPS) | 100 | 187.04 | +87.0% |
Synopsys, Inc. (SNPS) returned +63% over 5 years vs MicroAlgo Inc. (MLGO)'s -100%. A $10,000 investment in SNPS 5 years ago would be worth $16,288 today (including dividends reinvested).
Chart 2Revenue Growth — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| MicroAlgo Inc. (MLGO) | $16M | $74M | +364.6% |
| Synopsys, Inc. (SNPS) | $2.4B | $7.1B | +191.2% |
Synopsys, Inc.'s revenue grew from $2.4B (2016) to $7.1B (2025) — a 12.6% CAGR.
Chart 3Net Margin Trend — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| MicroAlgo Inc. (MLGO) | 39.0% | 7.1% | -81.7% |
| Synopsys, Inc. (SNPS) | 11.0% | 18.9% | +71.5% |
Synopsys, Inc.'s net margin went from 11% (2016) to 19% (2025).
Chart 4P/E Ratio History — 9 Years
| Stock | 2017 | 2025 | Change |
|---|---|---|---|
| Synopsys, Inc. (SNPS) | 96.9 | 58.4 | -39.7% |
Synopsys, Inc. has traded in a 30x–97x P/E range over 9 years; current trailing P/E is ~51x.
Chart 5EPS Growth — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| MicroAlgo Inc. (MLGO) | 29.45 | 0.55 | -98.1% |
| Synopsys, Inc. (SNPS) | 1.73 | 8.04 | +364.7% |
Synopsys, Inc.'s EPS grew from $1.73 (2016) to $8.04 (2025) — a 19% CAGR.
Chart 6Free Cash Flow — 5 Years
MicroAlgo Inc. generated $4M FCF in 2024 (-74% vs 2021). Synopsys, Inc. generated $1B FCF in 2025 (-3% vs 2021).
MLGO vs SNPS: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is MLGO or SNPS a better buy right now?
MicroAlgo Inc. (MLGO) offers the better valuation at 6.5x trailing P/E, making it the more compelling value choice. Analysts rate Synopsys, Inc. (SNPS) a "Buy" — based on 27 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — MLGO or SNPS?
On trailing P/E, MicroAlgo Inc. (MLGO) is the cheapest at 6.5x versus Synopsys, Inc. at 51.5x.
03Which is the better long-term investment — MLGO or SNPS?
Over the past 5 years, Synopsys, Inc. (SNPS) delivered a total return of +62.9%, compared to -100.0% for MicroAlgo Inc. (MLGO). A $10,000 investment in SNPS five years ago would be worth approximately $16K today (assuming dividends reinvested). Over 10 years, the gap is even starker: SNPS returned +825.1% versus MLGO's -100.0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — MLGO or SNPS?
By beta (market sensitivity over 5 years), MicroAlgo Inc. (MLGO) is the lower-risk stock at 0.16β versus Synopsys, Inc.'s 1.37β — meaning SNPS is approximately 772% more volatile than MLGO relative to the S&P 500. On balance sheet safety, MicroAlgo Inc. (MLGO) carries a lower debt/equity ratio of 16% versus 50% for Synopsys, Inc. — giving it more financial flexibility in a downturn.
05Which has better profit margins — MLGO or SNPS?
Synopsys, Inc. (SNPS) is the more profitable company, earning 18.9% net margin versus 7.1% for MicroAlgo Inc. — meaning it keeps 18.9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SNPS leads at 13.0% versus 3.7% for MLGO. At the gross margin level — before operating expenses — SNPS leads at 77.0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — MLGO or SNPS?
None of the stocks in this comparison currently pay a material dividend. All are effectively zero-yield and should be held for capital appreciation rather than income.
07Is MLGO or SNPS better for a retirement portfolio?
For long-horizon retirement investors, MicroAlgo Inc. (MLGO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.16)). Both have compounded well over 10 years (MLGO: -100.0%, SNPS: +825.1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between MLGO and SNPS?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both. In terms of investment character: MLGO is a small-cap deep-value stock; SNPS is a mid-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that beat both.